Emphysema: A Potential Risk Factor for Subarachnoid Hemorrhage and Ruptured Aortic Aneurysm

Background and Purpose— Protease/antiprotease imbalance is implicated in the pathogenesis of emphysema and may also lead to vessel wall weakening, aneurysm development, and rupture. However, it is unclear whether emphysema is associated with cerebral and aortic aneurysm rupture. Methods— We performed a retrospective cohort study using outpatient and inpatient claims data from 2008 to 2014 from a nationally representative sample of Medicare beneficiaries ≥66 years of age. Our predictor variable was emphysema, and our outcome was hospitalization for either aneurysmal subarachnoid hemorrhage or a ruptured aortic aneurysm. All predictors and outcomes were defined using previously reported International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code algorithms. Survival statistics and Cox regression were used to compare risk between patients with and without emphysema. Results— We identified 1 670 915 patients, of whom 133 972 had a diagnosis of emphysema. During a mean follow-up period of 4.3 (±1.9) years, we identified 4835 cases of aneurysm rupture, 433 of which occurred in patients with emphysema. The annual incidence of aneurysm rupture was 6.5 (95% CI, 6.4–6.8) per 10 000 in patients without emphysema and 14.6 (95% CI, 13.3–16.0) per 10 000 in patients with emphysema. After adjustment for demographics and known risk factors for aneurysmal disease, emphysema was independently associated with aneurysm rupture (hazard ratio, 1.7; 95% CI, 1.5–1.9). Emphysema was associated with both aneurysmal subarachnoid hemorrhage (hazard ratio, 1.5; 95% CI, 1.3–1.7) and ruptured aortic aneurysm (hazard ratio, 2.3; 95% CI, 1.9–2.8). Conclusions— Patients with emphysema face an increased risk of developing subarachnoid hemorrhage and aortic aneurysm rupture, potentially consistent with shared pathways in pathogenesis.

[1]  H. Kamel,et al.  Pregnancy and the Risk of Aortic Dissection or Rupture: A Cohort-Crossover Analysis , 2016, Circulation.

[2]  B. Hedblad,et al.  Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease , 2016, European Journal of Epidemiology.

[3]  A. Plummer International Classification of Diseases, Tenth Revision, Clinical Modification for the Pulmonary, Critical Care, and Sleep Physician. , 2015, Chest.

[4]  P. Sorroche,et al.  Alpha-1 Antitrypsin Deficiency in COPD Patients: A Cross-Sectional Study. , 2015, Archivos de bronconeumologia.

[5]  A. Woźniak,et al.  Activity of α 1-Antitrypsin and Some Lysosomal Enzymes in the Blood Serum of Patients with Chronic Obstructive Pulmonary Disease after Smoking Cessation , 2015, BioMed research international.

[6]  Z. Bartuzi,et al.  [Balance of proteinases and antiproteinases and smoking tobacco]. , 2011, Pneumonologia i alergologia polska.

[7]  K. Gardiner,et al.  Successful endovascular treatment of multiple mesenteric arterial aneurysms associated with alpha-1-antitrypsin deficiency. , 2010, Journal of vascular surgery.

[8]  R. Abboud,et al.  Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[9]  Louette R. Johnson Lutjens Research , 2006 .

[10]  W. Longstreth,et al.  Validating Administrative Data in Stroke Research , 2002, Stroke.

[11]  K. Nakayama,et al.  Absence of plasma protease-antiprotease imbalance in the formation of saccular cerebral aneurysms. , 1999, Neurosurgery.

[12]  J. Parisi,et al.  Giant intracranial aneurysm and fibromuscular dysplasia in an adolescent with α1-antitrypsin deficiency: Case report , 1996 .

[13]  D. Schaid,et al.  Alpha-1-antitrypsin phenotypes among patients with intracranial aneurysms. , 1996, Journal of neurosurgery.

[14]  B. Mokri,et al.  α1-antitrypsin deficiency in intracranial aneurysms and cervical artery dissection , 1994, The Lancet.

[15]  M. Goumans,et al.  Chapter 2 . 3 Mutations in a TGFß ligand , TGFB 3 , cause syndromic aortic aneurysms and dissections Mutations in TGFB 3 cause syndromic aortic aneurysms and dissections , 2019 .

[16]  J. Parisi,et al.  Giant intracranial aneurysm and fibromuscular dysplasia in an adolescent with alpha 1-antitrypsin deficiency. , 1996, Journal of neurosurgery.

[17]  B. Mokri,et al.  Alpha 1-antitrypsin deficiency in intracranial aneurysms and cervical artery dissection. , 1994, Lancet.